NCT00243464

Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp Psoriasis

Calcipotriol Plus Betamethasone Dipropionate Gel Compared to DAIVONEX/DOVONEX Scalp Solution in Patients With Scalp Psoriasis

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 300 (planned)
• Sponsor: LEO Pharma · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate whether once daily treatment for up to 8 weeks of calcipotriol plus betamethasone dipropionate gel is more effective than twice daily treatment of calcipotriol scalp solution in patients with scalp psoriasis. The primary outcome is patients with clear or minimal disease after 8 weeks treatment. Further the occurrence of relapse and rebound after end of treatment in patients with clear or minimal disease will be investigated.

Conditions

• Psoriasis of Scalp

Interventions

Type	Name	Description
DRUG	Calcipotriol plus betamethasone dipropionate (LEO80185 gel)

Timeline

• Start date: 2005-09-01
• Completion: 2006-05-01
• First posted: 2005-10-24
• Last updated: 2025-02-24

Locations

5 sites across 5 countries: Belgium, Canada, Denmark, France, Sweden